MX2016015364A - Acido hialurónico entrelazado injertado con dextrán. - Google Patents

Acido hialurónico entrelazado injertado con dextrán.

Info

Publication number
MX2016015364A
MX2016015364A MX2016015364A MX2016015364A MX2016015364A MX 2016015364 A MX2016015364 A MX 2016015364A MX 2016015364 A MX2016015364 A MX 2016015364A MX 2016015364 A MX2016015364 A MX 2016015364A MX 2016015364 A MX2016015364 A MX 2016015364A
Authority
MX
Mexico
Prior art keywords
hyaluronic acid
cross
dextran
linked hyaluronic
acid grafted
Prior art date
Application number
MX2016015364A
Other languages
English (en)
Other versions
MX367853B (es
Inventor
Anders Karlsson
MOJARRADI Hotan
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of MX2016015364A publication Critical patent/MX2016015364A/es
Publication of MX367853B publication Critical patent/MX367853B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/02Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075Macromolecular gels
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/24Crosslinking, e.g. vulcanising, of macromolecules
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02Dextran; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/02Dextran; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2351/00Characterised by the use of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives of such polymers
    • C08J2351/02Characterised by the use of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives of such polymers grafted on to polysaccharides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/02Applications for biomedical use

Abstract

Se describe un producto de ácido hialurónico que comprende un ácido entrelazado y una o más moléculas; el ácido hialurónico es entrelazado por enlaces de éter, y la una o más moléculas de dextran son injertadas covalentemente al ácido hialurónico entrelazado.
MX2016015364A 2014-05-29 2015-05-29 Ácido hialurónico entrelazado injertado con dextrán. MX367853B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462004285P 2014-05-29 2014-05-29
PCT/EP2015/062010 WO2015181369A1 (en) 2014-05-29 2015-05-29 Cross-linked hyaluronic acid grafted with dextran

Publications (2)

Publication Number Publication Date
MX2016015364A true MX2016015364A (es) 2017-07-27
MX367853B MX367853B (es) 2019-09-09

Family

ID=53269495

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016015364A MX367853B (es) 2014-05-29 2015-05-29 Ácido hialurónico entrelazado injertado con dextrán.

Country Status (10)

Country Link
US (1) US10131718B2 (es)
EP (1) EP3148511A1 (es)
JP (1) JP2017517601A (es)
KR (1) KR20170026377A (es)
CN (1) CN106661133A (es)
AU (1) AU2015265809A1 (es)
CA (1) CA2950050A1 (es)
MX (1) MX367853B (es)
RU (1) RU2016150853A (es)
WO (1) WO2015181369A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016192760A1 (en) * 2015-05-29 2016-12-08 Galderma S.A. Mixed hydrogels of hyaluronic acid and dextran
EP3397648B1 (en) 2015-12-29 2020-05-27 Galderma S.A. Method for deacetylation of biopolymers
EP3252081A1 (en) * 2016-05-31 2017-12-06 Galderma S.A. Hydrolysis of ester bonds in amide crosslinked glycosaminoglycans
US10058502B2 (en) 2015-12-31 2018-08-28 L'oreal Nail polish compositions
PT3623390T (pt) 2016-05-31 2023-10-27 Galderma Sa Reticulador de hidrato de carbono
WO2019002369A1 (en) * 2017-06-28 2019-01-03 Nestlé Skin Health Sa GLYCOSAMINOGLYCAN HYDROGEL WITH DEXTRANE OR GRAFT CYCLODEXTRIN
WO2019002372A1 (en) * 2017-06-28 2019-01-03 Nestlé Skin Health Sa PROCESS FOR PREPARING A HYDROGEN PRODUCT
WO2019002368A1 (en) * 2017-06-28 2019-01-03 Nestlé Skin Health Sa GLYCOSAMINOGLYCANES RETICULATED AND FUNCTIONALIZED
WO2019059437A1 (ko) * 2017-09-25 2019-03-28 김재현 덱스트란 기반의 창상 피복재 및 창상 피복재의 제조방법
CN112384258A (zh) 2018-05-09 2021-02-19 约翰·霍普金斯大学 用于细胞和组织递送的纳米纤维-水凝胶复合物
KR102088107B1 (ko) * 2018-07-19 2020-03-11 아주대학교산학협력단 염증 억제 펩타이드의 물리적/화학적 함유 주사 제형 전달체, 이의 제조 방법 및 응용
KR102051467B1 (ko) * 2019-06-12 2019-12-03 박상준 피부 충전제 조성물 및 이의 제조방법
EP4069753A1 (en) 2019-12-02 2022-10-12 Galderma Holding SA High molecular weight esthetic compositions
CN111732675A (zh) * 2020-08-18 2020-10-02 山东华熙海御生物医药有限公司 透明质酸-氨基葡萄糖接枝共聚物、制法及其应用
KR102527555B1 (ko) * 2020-11-24 2023-05-03 가톨릭대학교 산학협력단 코어-쉘 마이크로입자 및 이의 제조방법
CN113730577B (zh) * 2021-09-07 2022-11-08 浙江大学 一种侧链接枝有苯硼酸的具有消除活性氧功能的席夫碱水凝胶材料及其制备方法
CN114316087B (zh) * 2021-12-31 2022-10-28 常州百瑞吉生物医药有限公司 一种透明质酸交联活性材料、制备方法及其应用
WO2024038936A1 (ko) * 2022-08-19 2024-02-22 주식회사 베스트앤퍼스트바이오텍 가교 공중합체, 이의 제조 방법 및 이를 포함하는 패치

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827937A (en) * 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
WO2003047462A1 (en) * 2001-03-12 2003-06-12 Clemson University Polysaccharide-based polmerizable hydrogels
CA2534033A1 (fr) * 2003-07-30 2005-02-10 Anteis S.A. Matrice complexe a usage biomedical
WO2010065784A2 (en) * 2008-12-03 2010-06-10 Jakk Group, Inc. Methods, devices, and compositions for dermal filling
US20120301441A1 (en) * 2009-11-11 2012-11-29 Hermanus Bernardus Johannes Karperien Dextran-hyaluronic acid based hydrogels
ES2791180T3 (es) 2012-10-02 2020-11-03 Allergan Inc Hidrogeles de relleno dérmico con complejos de inclusión de vitamina A/ciclodextrina
JP2016524644A (ja) 2013-06-14 2016-08-18 ガルデルマ エス.エー. 架橋ヒアルロン酸及びシクロデキストリンを含む組成物

Also Published As

Publication number Publication date
KR20170026377A (ko) 2017-03-08
EP3148511A1 (en) 2017-04-05
CA2950050A1 (en) 2015-12-03
US20180244807A1 (en) 2018-08-30
MX367853B (es) 2019-09-09
US10131718B2 (en) 2018-11-20
CN106661133A (zh) 2017-05-10
RU2016150853A (ru) 2018-07-02
WO2015181369A1 (en) 2015-12-03
JP2017517601A (ja) 2017-06-29
AU2015265809A1 (en) 2016-12-08

Similar Documents

Publication Publication Date Title
MX367853B (es) Ácido hialurónico entrelazado injertado con dextrán.
PH12019502875A1 (en) Antibody molecules to cd73 and uses thereof
MX2019003489A (es) Moleculas del receptor de envolvimiento quimerico.
PH12018501206A1 (en) Antibody molecules to pd-1 and uses thereof
MX2022001043A (es) Moleculas de anticuerpo que se unen a lag-3 y usos de las mismas.
MX2017008105A (es) Injerto de ciclodextrina mediante enlaces amida a un acido hialuronico reticulado a eter y sus usos.
MX2020002694A (es) Moleculas de anticuerpo que se unen a tim-3 y usos de las mismas.
PH12016501763A1 (en) Multispecific antibodies
PH12016501456A1 (en) Antibody molecules to pd-1 and uses thereof
MX2020007266A (es) Moleculas del receptor quimerico de engullido y metodos de uso.
WO2017091683A8 (en) Antibody molecules to april and uses thereof
NZ733055A (en) Anti-c10orf54 antibodies and uses thereof
MX2016014296A (es) Proceso para preparar un poliol polimerico.
MX2017006899A (es) Sintesis de polioles polimericos en polioles insaturados, polioles polimericos y su uso.
MX2016010229A (es) Conjugados del factor vii.
MX2016001691A (es) Moleculas de union al receptor bag3 para uso como un medicamento.
MX2016009774A (es) Ensayo biologico de peptidoglicanos.
MX366815B (es) Polioles, su preparación y su uso.
AU356405S (en) Container
AU355660S (en) Chair

Legal Events

Date Code Title Description
FG Grant or registration